|Published by:||Indian Journal of Dermatology|
Guideline discusses the use of various surgical procedures for the treatment of post-acne scarring and as adjuvant treatment for active acne. Surgery is indicated both in active acne and post-acne scars.
|Published by:||British Association of Dermatologists|
Isotretinoin should not be given to patients with hypervitaminosis A, to those with uncontrolled hyperlipidaemia, or to patients who are pregnant or lactating. Care should also be taken when prescribing to patients with renal or liver disease. This guideline discusses in detail 2 specific adverse effects of isotretinoin that should be considered: risk of teratogenicity and mood change.
|Published by:||Medicines and Healthcare products Regulatory Agency|
Guidelines provide a summary of advice on the use of isotretinoin for the treatment of severe acne. Isotretinoin is an effective treatment for severe acne but should not be used by some patients, such as those who are pregnant or considering becoming pregnant.
|Published by:||Global Alliance to Improve Outcomes in Acne|
Discusses the pathophysiology involved in acne vulgaris, as well as details regarding the use and mechanism of topical retinoids, antimicrobial therapy, hormonal therapy, oral retinoids, and adjunctive therapies.